Curecall is a France-based startup, founded in 2020, that offers a solution to simplify patient follow-up. With the slogan "Le suivi patient simplifié", Curecall aims to automate patient follow-ups through SMS using their medical conversational agent. This automation can potentially save up to 6 hours of paramedical time each week.
The startup operates in the B2B, Health Care, IT, Information Technology, and Messaging industries, positioning itself at the intersection of healthcare and technology. Their customized solution is designed to adapt to various care pathways and practices, offering an API-based approach that seamlessly integrates with existing tools and evolves to meet changing needs without hidden costs.
Notably, Curecall recently secured a €800.00K investment in a Corporate Round on 19 April 2021 from Unither Pharmaceuticals, indicating growing investor interest in the promising potential of their innovative approach to patient follow-up.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Corporate Round | €800.00K | 1 | Unither Pharmaceuticals | 19 Apr 2021 |
Corporate Round | €400.00K | 1 | Unither Pharmaceuticals | 23 Jun 2020 |
No recent news or press coverage available for Curecall.